Company: Solarvest Bioenergy Inc.
Listing : TSX Venture,Frankfurt
Ticker: SVS.V , 0ZJ:FRA
Market cap at time of publication: $24.4 MCAD
Stock price at time of publication: $0.46 CAD
Business: Patented plant based pharmaceuticals from algaes and Clean Energy Hydrogen production
Comparable peers: Else Nutrition market cap : 306 MCAD
Website:http://www.solarvest.ca/ and for the omega 3 products: https://eversea.ca/
Great news today (27/4 2021) for Solarvest Bioenergy (previously covered by ESGFIRE) as they announced that they have received patent approvals “in Australia and India. The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins. These patents add additional strength to the Company’s existing patent portfolio as it commercializes its line of organic Omega-3 products.”
Solarvest also discloses that they aim to launch their organic omega 3 product globally with a “clean label” and a “white label” approach. This means house branded products based on their unique bioavailable Omega3 ingredient. The company states there has been massive interest from the market for their unique organic omega 3 product line. The product has FDA NDI (New Dietary Ingredient) certification, and is USDA and EU Organic Certified.
The new patent approvals along with the MASSIVE communicated interest for Solarvest Bioenergy’s uniquely patented omega 3 product with sustainable production from algae bodes well for the coming massive sales launch that we anticipare from the company. We hope that the compant might even be able to break our projected sales of 2.5-3 MCAD for 2021. We have previously stated we see an upside of 480 % from current levels into 2022 if the company follows our projection.
What we consider MOST interesting is the fact that the company “has received substantial interest due to the timely introduction of a premium ingredient when the reality of chemical and heavy metal contamination in baby food has been brought to light.
There seems to be a BIG demand for an organic additive of omega 3 from the baby food industry. The company also states in the press release that ” Organic marketers fully recognize the value of chemical free production as a competitive advantage. Moreover, in
terms of intellectual property protection, the IP has been described as a rare commodity in a growing market segment”
To conclude it has to be said that the new white label and clean label approach simplifies and makes it MUCH cheaper to get to market with the organic omega 3 product segment!
I own shares of this company personally.
Investing in stocks is combined with certain risks and it is possible to lose your entire investment. My posts are made for Educational purposes only and are not to be interpreted as tips , financial advise or recommendations of any kind to either buy or sell any stocks.
Companies may or may not be paying me for content posted on this blog.